Skip to content
Biofil Chemicals logo

Biofil Chemicals

BIOFILCHEM NSE
₹29.26 0.66 (2.21%)
Market Cap
₹47.62 Cr
P/E
97.53

Biofil Chemicals (BIOFILCHEM) share price was ₹29.26 at the 28 Oct 2026 close; market capitalisation ₹47.62 Cr; P/E (TTM) 97.53; sector Healthcare. The share price fell 25.6% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 92.1% year on year to ₹12.35 Cr and net profit fell 95.4% year on year to ₹0.11 Cr (compared with Jun 2025). Promoters held 46.79% of Biofil Chemicals in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 42/100 (Weak) as of 28 Oct 2026.

Close 28 Oct 2026 ₹29.26 −10.04 −25.55% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹47.62 Cr
P/E (TTM)
97.53
EBITDA
₹3.70 Cr
Return on Equity
12.92%
Debt to Equity
0.14
Book Value
₹13.25
EPS (TTM)
₹0.30
52W High
₹46.34
52W Low
₹25.60

Price-based figures as of 28 Oct 2026, 15:52 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,757.5034.864,21,683 Cr5.050.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,558.5086.752,53,748 Cr15.140.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,557.0071.541,73,334 Cr9.430.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,181.90107.801,17,891 Cr22.240.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,175.5026.161,17,257 Cr4.330.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,335.4034.591,11,463 Cr2.870.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,365.6032.721,10,321 Cr3.120.96%11.21%14.88%28,589 Cr3,356 Cr
Biofil Chemicals (this company)
₹29.2697.5348 Cr2.210.00%12.92%15.61%35 Cr0 Cr
Median 8 companies₹1,561.5553.201,17,574 Cr4.690.47%13.36%16.78%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

As of 2026-10-28
v2.0.0
42 Weak
Overall score
Data confidence 98/100

Category scores

Quality Average 45
Returns, margins, earnings quality 22%
Valuation Poor 26
Cheap vs sector & own history 24%
Growth Average 50
Sales & profit trajectory 9%
Financial Health Average 46
Solvency, leverage, coverage 9%
Momentum Poor 34
Trend strength, vol-adjusted 12%
Ownership Average 50
FII/DII/promoter flows 24%

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company is expected to give good quarter

Weaknesses

5
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -4.50% over past five years.
  • Company has a low return on equity of 1.24% over last 3 years.
  • Earnings include an other income of Rs.0.31 Cr.
  • Company has high debtors of 355 days.

Technical Indicators

Oscillators

BearishNeutralBullish

Bearish

Bearish
2
Neutral
7
Bullish
0

Overall

BearishNeutralBullish

Bearish

Bearish
12
Neutral
7
Bullish
0

Moving Averages

BearishNeutralBullish

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
-6.53% lower than 3Y

change over 1 year

Net Income Growth
367% higher than 3Y

change over 1 year

Cash Flow Change
68.75%

change over 1 year

EBITDA Margin Change
247%

change over 1 year Operating margin 1.13% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
2.43
17.37
5.03
15.2
8.44
2.41
14.2
8.35
6.43
13.54
0.86
7.57
12.35
Expenses
2.01
17.13
4.84
15.24
8.13
2.29
13.89
8.24
6.42
13.42
0.77
7.14
12.21
Operating Profit
0.42
0.24
0.19
-0.04
0.31
0.12
0.31
0.11
0.01
0.12
0.09
0.43
0.14
OPM %
17.28%
1.38%
3.78%
-0.26%
3.67%
4.98%
2.18%
1.32%
0.16%
0.89%
10.47%
5.68%
1.13%
Other Income
0.02
0.03
0.03
0.41
0.03
0.02
0.02
0.24
2.83
0.06
0.08
0.11
0.06
Interest
0.01
0.01
0
0.02
0.01
0.01
0.01
0.01
0.01
0
0
0
0
Depreciation
0.11
0.11
0.11
0.08
0.1
0.1
0.1
0.08
0.07
0.07
0.07
0.07
0.07
PBT
0.32
0.15
0.11
0.27
0.23
0.03
0.22
0.26
2.76
0.11
0.1
0.47
0.13
Tax %
25%
20%
18.18%
11.11%
26.09%
33.33%
27.27%
23.08%
12.68%
27.27%
30%
55.32%
23.08%
Net Profit
0.24
0.12
0.09
0.25
0.17
0.02
0.16
0.2
2.41
0.08
0.08
0.21
0.11
EPS (₹)
0.15
0.07
0.06
0.15
0.1
0.01
0.1
0.12
1.48
0.05
0.05
0.13
0.07
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
5.86
13.17
13.45
12.36
23.13
29.69
35.75
22.38
30.04
40.04
33.4
28.4
34.32
Expenses
5.12
12.3
10.84
11.43
22.11
27.87
34.15
21.05
28.88
39.23
32.55
27.75
33.54
Operating Profit
0.74
0.87
2.61
0.93
1.02
1.82
1.6
1.33
1.16
0.81
0.85
0.65
0.78
OPM %
12.63%
6.61%
19.41%
7.52%
4.41%
6.13%
4.48%
5.94%
3.86%
2.02%
2.54%
2.29%
2.27%
Other Income
0.46
0.53
0.14
0.1
0.1
0.17
0.8
0.15
0.1
0.49
0.31
3.08
0.31
Interest
0.21
0.15
0.16
0.15
0.16
0.12
0.07
0.04
0.04
0.04
0.04
0.01
0
Depreciation
0.25
0.26
0.28
0.3
0.37
0.41
0.41
0.43
0.43
0.4
0.38
0.27
0.28
PBT
0.74
0.99
2.31
0.58
0.59
1.46
1.92
1.01
0.79
0.86
0.74
3.45
0.81
Tax %
20.27%
20.2%
22.51%
20.69%
20.34%
17.81%
34.9%
31.68%
29.11%
17.44%
24.32%
19.13%
—
Net Profit
0.59
0.78
1.79
0.47
0.48
1.21
1.24
0.7
0.56
0.71
0.56
2.79
0.48
EPS (₹)
0.36
0.48
1.1
0.29
0.29
0.74
0.76
0.43
0.34
0.44
0.34
1.71
0.3
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
16.27
16.27
16.27
16.27
16.27
16.27
16.27
16.27
16.27
16.27
16.27
16.27
Reserves
-7.86
-5.37
-3.58
-3.11
-2.62
-1.39
-0.14
0.56
1.03
1.93
2.51
5.29
Borrowings
2.98
1.37
1.43
1.56
1.64
1.19
0.43
0.46
0.52
0.44
0.47
3.02
Other Liabilities
2.36
11.87
7.72
9.44
8.93
26.3
16.68
1.44
13.58
28.44
31.7
18.26
Total Liabilities
13.75
24.14
21.84
24.16
24.22
42.37
33.24
18.73
31.4
47.08
50.95
42.84
Fixed Assets
9.06
8.98
9.16
9.25
10.29
10.09
9.78
9.42
9
8.62
8.34
6.94
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
4.69
15.16
12.68
14.91
13.93
32.28
23.46
9.31
22.4
38.46
42.61
35.9
Total Assets
13.75
24.14
21.84
24.16
24.22
42.37
33.24
18.73
31.4
47.08
50.95
42.84
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.01
0.14
0.71
0.46
1.26
0.89
1.11
-0.22
-0.11
2.39
-1.92
-0.6
Investing
-0.17
-0.19
-0.48
-0.38
-1.41
-0.21
-0.1
-0.07
-0.01
-0.02
-0.1
1.14
Financing
0.11
0.1
-0.11
-0.02
-0.08
-0.57
-0.83
-0.01
0.02
-0.12
0
2.54
Net Cash Flow
-0.05
0.05
0.13
0.06
-0.24
0.12
0.18
-0.3
-0.11
2.25
-2.03
3.07
Free Cash Flow
-0.16
-0.05
0.23
0.08
-0.15
0.68
1.01
-0.29
-0.12
2.37
-2.02
0.54
CFO/OP
19
33
35
103
134
63
112
8
10
314
-205
9
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
227
387
311
383
190
365
176
117
249
301
419
355
Inventory Days
15.99
3.46
7.29
38.11
21.73
24.37
48.85
24.2
16.11
24.81
39.52
56.24
Days Payable
198
401
305
341
157
374
178
11.25
168
268
367
240
Cash Conversion Cycle
44.85
-10.07
13.76
79.95
54.9
15.82
46.27
130
96.8
57.83
91.63
171
Working Capital Days
-47.96
48.5
87.65
105
50.81
55.69
64.12
125
104
69.37
114
152
ROCE %
8.59%
9.64%
18.72%
5.06%
5%
10.08%
12.2%
6.2%
4.73%
4.94%
4.12%
2.97%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Biofil Chemicals insights

62 extracted metrics + investor summaries across FY11–FY27.

Shareholding Pattern

DIIs0.08%Promot.46.79%Others14.58%Public38.54%As ofSep 2026

Documents

Frequently Asked Questions about Biofil Chemicals

What does Biofil Chemicals & Pharmaceuticals Ltd do?
Incorporated in 1993, Biofil Chemicals and Pharmaceuticals Ltd deals in Pharmaceuticals and Chemicals products.[1]
Where is Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) listed?
Biofil Chemicals & Pharmaceuticals Ltd trades as BIOFILCHEM on the NSE and under code 524396 on the BSE.
Which sector does Biofil Chemicals & Pharmaceuticals Ltd belong to?
Biofil Chemicals & Pharmaceuticals Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Biofil Chemicals & Pharmaceuticals Ltd?
Biofil Chemicals & Pharmaceuticals Ltd has a market capitalisation of ₹47.62 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Biofil Chemicals & Pharmaceuticals Ltd?
Biofil Chemicals & Pharmaceuticals Ltd trades at a PE ratio of 97.53 as of 28 Oct 2026, on earnings per share of ₹0.3, against a book value of ₹13.25 per share.
What is the 52-week high and low of Biofil Chemicals & Pharmaceuticals Ltd?
Over the last 52 weeks Biofil Chemicals & Pharmaceuticals Ltd has traded between ₹25.6 and ₹46.34 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Biofil Chemicals & Pharmaceuticals Ltd?
Biofil Chemicals & Pharmaceuticals Ltd reported a return on equity of 12.92%. Its debt-to-equity ratio is 0.14.

Company Information

Incorporated in 1993, Biofil Chemicals and Pharmaceuticals Ltd deals in Pharmaceuticals and Chemicals products.[1]

Website biofilgroup.net
CEO Mr. Ketan Shah
Employees 26
Listed 1996-06-12
Face Value ₹ 10
Shares Outstanding 1,62,73,800

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/BIOFILCHEM.md for Biofil Chemicals & Pharmaceuticals Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month